MAIA Biotechnology, Inc.
MAIA
$1.59
$0.00530.34%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.75% | 9.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.78% | 8.41% | |||
| Operating Income | 4.78% | -8.41% | |||
| Income Before Tax | -18.37% | -26.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.37% | -26.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.37% | -26.47% | |||
| EBIT | 4.78% | -8.41% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -8.22% | -14.38% | |||
| Normalized Basic EPS | -8.24% | -14.24% | |||
| EPS Diluted | -8.22% | -14.38% | |||
| Normalized Diluted EPS | -8.24% | -14.24% | |||
| Average Basic Shares Outstanding | 9.40% | 10.61% | |||
| Average Diluted Shares Outstanding | 9.40% | 10.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||